Company Profile

Ossium Health Inc
Profile last edited on: 9/26/22      CAGE: 7QL09      UEI: FFNHJ2RDRHW3

Business Identifier: Bone marrow bank to treat blood cancers
Year Founded
2016
First Award
2017
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1121 Howard Sttreet
San Francisco, CA 94103
   (415) 513-5535
   info@ossiumhealth.com
   www.ossiumhealth.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

The management of Ossium define their mission as improving human health by driving niotechnology innovation that fosters the preservation of life. At its core, the firm's objective is anchored in the understanding that cells of the immune system are the human body’s natural defenders against disease. The objective therefore is to develop better methods of recovering, preserving, and deploying these critical cells that serve to keep disease at bay. Soecifically, to address the shortage of life-saving stem cells for transplant - to match the needs of hundreds of thousands iof patients - Ossium Health is building what could be the world’s bone marrow bank. Every year, new patients with sickle cell, leukemia, lymphoma, etc, need hematopoietic stem cell transplants to survive -- an estimated $20B market in US alone. These transplants are among the most powerful medical procedures - involving the replacement of someone’s entire blood and immune systems. There is a major shortage of the relevent bone marrow. Consequence: long wait-list in the US with almost 2/3rds dying before receiving a matched transplant. Ossium is focused on addressing this shortage by building a global bone marrow bank from previously untapped sou

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Kevin Caldwell -- Co-Founder, President & CEO

  Erik J Woods -- Co-Founder; Chief Executive Officer; President

  Emily Hopewell

  Brian Johnstone

  Aubrey Sherry -- Cellular Therapy Technologis

  Bram Sterling -- Research Fellow

  Erik J Woods -- Co Founder and Chief Science Officer

Company News

There are no news available.